Vice President, Market Access & Strategy, Commercial

Cabaletta Bio Inc.Philadelphia, PA
Hybrid

About The Position

Reporting to the Chief Commercial Officer, the Vice President (VP), Market Access & Strategy is responsible for establishing the strategic foundation for pricing, reimbursement, policy, and evidence generation to support successful commercialization of Cabaletta Bio’s CAR-T therapies. This role ensures optimal access through strong value demonstration, reimbursement infrastructure, and proactive policy strategy.

Requirements

  • Advanced degree preferred (MBA, PhD, PharmD, MD, or equivalent).
  • 15+ years of experience in pricing, reimbursement, market access strategy, or HEOR.
  • Deep expertise in Medicare/Medicaid policy, coding, and reimbursement frameworks.
  • Experience in cell/gene therapy or complex specialty products strongly preferred.
  • Strong analytical, strategic, and cross-functional leadership skills.

Responsibilities

  • Lead development of U.S. pricing strategy aligned with product value, market dynamics, and access goals.
  • Lead Medicare billing, coding development, and submission processes.
  • Oversee Medicaid strategy and execution across states.
  • Develop and implement provider reimbursement strategies, including coding and payment pathways.
  • Lead Health Economics and Outcomes Research (HEOR) strategy.
  • Partner with Medical Affairs to generate evidence supporting payer value propositions.
  • Oversee payer and hospital market research to inform pricing, access strategy, and evidence needs.
  • Monitor and shape healthcare policy impacting reimbursement and access.
  • Engage with external stakeholders and industry groups.
  • Lead development of payer-focused materials and promotional tools to communicate value effectively.
  • Co-lead payer and hospital advisory boards to refine strategy and gather insights.
  • Partner with New Product Planning (NPP) on future indications and business development opportunities.

Benefits

  • competitive benefits
  • PTO
  • stock option plans
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service